Abraha Hiluf Ebuy, Gessesse Zekarias, Gebrecherkos Teklay, Kebede Yazezew, Weldegiargis Aregawi Weldegebreal, Tequare Mengistu Hagazi, Welderufael Abadi Luel, Zenebe Dawit, Gebremariam Asqual Gebreslassie, Dawit Tsega Cherkos, Gebremedhin Daniel Woldu, de Wit Tobias Rinke, Wolday Dawit
Mekelle University College of Health Sciences, Mekelle, Ethiopia.
Deutsche Gesellschaft fϋr Internationale Zusammenarbeit, GMBH, Nutrition Sensitive Agriculture Project in Mekelle, Ethiopia.
Int J Infect Dis. 2021 Apr;105:776-783. doi: 10.1016/j.ijid.2021.03.037. Epub 2021 Mar 16.
To describe the clinical features and assess the determinants of severity and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) from a unique setting in Ethiopia.
Consecutive patients admitted to a COVID-19 isolation and treatment centre were included in this study. The overall clinical spectrum of COVID-19, and factors associated with risk of severe COVID-19 and in-hospital mortality were analysed.
Of 2617 quarantined patients, three-quarters (n = 1935, 74%) were asymptomatic and only 114 (4.4%) presented with severe COVID-19. Common characteristics among the 682 symptomatic patients were cough (n = 354, 50.6%), myalgia (n = 212, 31.1%), headache (n = 196, 28.7%), fever (n = 161, 23.6%), dyspnoea (n = 111, 16.3%), anosmia and/or dysgeusia (n = 90, 13.2%), sore throat (n = 87, 12.8%) and chest pain (n = 77, 11.3%). Factors associated with severe COVID-19 were older age [adjusted relative risk (aRR) 1.78, 95% confidence interval (CI) 1.61-1.97; P < 0.0001], diabetes (aRR 2.00, 95% CI 1.20-3.32; P = 0.007), cardiovascular disease (aRR 2.53, 95% CI 1.53-4.17; P < 0.0001), malignancy (aRR 4.57, 95% CI 1.62-12.87; P = 0.004), surgery/trauma (aRR 23.98, 95% CI 10.35-55.57; P < 0.0001) and human immunodeficiency virus infection (aRR 4.24, 95% CI 1.55-11.61; P = 005). Factors associated with risk of in-hospital mortality included older age (aRR 2.37, 95% CI 1.90-2.95; P < 0.001), malignancy (aRR 6.73, 95% CI 1.50-30.16; P = 0.013) and surgery/trauma (aRR 59.52, 95% CI 12.90-274.68; P < 0.0001).
A significant proportion of cases of COVID-19 were asymptomatic, and key comorbid conditions increased the risk of severe COVID-19 and in-hospital mortality. These findings could help in the design of appropriate management strategies for patients.
描述2019冠状病毒病(COVID-19)患者的临床特征,并评估埃塞俄比亚一个独特环境中COVID-19患者严重程度和院内死亡率的决定因素。
本研究纳入了连续入住COVID-19隔离治疗中心的患者。分析了COVID-19的总体临床谱,以及与重症COVID-19风险和院内死亡率相关的因素。
在2617名隔离患者中,四分之三(n = 1935,74%)无症状,仅有114名(4.4%)表现为重症COVID-19。682名有症状患者的常见特征包括咳嗽(n = 354,50.6%)、肌痛(n = 212,31.1%)、头痛(n = 196,28.7%)、发热(n = 161,23.6%)、呼吸困难(n = 111,16.3%)、嗅觉减退和/或味觉障碍(n = 90,13.2%)、咽痛(n = 87,12.8%)和胸痛(n = 77,11.3%)。与重症COVID-19相关的因素包括高龄[调整后相对风险(aRR)1.78,95%置信区间(CI)1.61 - 1.97;P < 0.0001]、糖尿病(aRR 2.00,95% CI 1.20 - 3.32;P = 0.007)、心血管疾病(aRR 2.53,95% CI 1.53 - 4.17;P < 0.0001)、恶性肿瘤(aRR 4.57,95% CI 1.62 - 12.87;P = 0.004)、手术/创伤(aRR 23.98,95% CI 10.35 - 55.57;P < 0.0001)和人类免疫缺陷病毒感染(aRR 4.24,95% CI 1.55 - 11.61;P = 0.005)。与院内死亡风险相关的因素包括高龄(aRR 2.37,95% CI 1.90 - 2.95;P < 0.001)、恶性肿瘤(aRR 6.73,95% CI 1.50 - 30.16;P = 0.013)和手术/创伤(aRR 59.52,95% CI 12.90 - 274.68;P < 0.0001)。
相当一部分COVID-19病例无症状,关键合并症会增加重症COVID-19和院内死亡率的风险。这些发现有助于为患者设计适当的管理策略。